Free Access: Seminal Paper on Integrating Top 10 Dietary Supplements Into Cancer Care
A new paper titled Integrating Dietary Supplements Into Cancer Care, authored by the Clinical Practice Committee of the Society for Integrative Oncology, will be published in the October/November 2013 edition of SAGE's Integrative Cancer Therapies, edited by Keith I Block, MD.
SAGE has graciously made the article available, accessible here for 30 days, starting September 1, 2013.
A significant portion of cancer patients are now using dietary supplements. However, patients often don't report their use of supplementation to their providers. Moreover, physicians have varying levels of understanding and experience with supplements and their use with oncology patients.
"Today's informed patients truly value physicians who appreciate them as equal participants in making their healthcare choices." ~Moshe Frenkel, MD
This important paper, written by leading researchers and clinicians with extensive experience using supplements, features the following 10 natural agents as having some of the strongest suggested benefits and evidence of effectiveness for cancer care:
1. Curcumin
2. Glutamine
3. Vitamin D
4. Maitake Mushrooms
5. Fish Oil
6. Green Tea
7. Milk Thistle
8. Astragalus
9. Melatonin
10. Probiotics
As the article states, "The information was constructed to provide an up-to-date base of knowledge, so that physicians and other healthcare providers would be aware of the supplements and be able to discuss realistic expectations and potential benefits and risks." Read the entire paper here.
This article will be discussed during session conducted by lead author Dr. Moshe Frenkel during 10th International Conference of the Society for Integrative Oncology (SIO) in Vancouver.
For registration information on the 10th International Conference of the Society for Integrative Oncology, click here.
Media and marketing veteran Glenn Sabin is a 22-year cancer "thriver" who created a comprehensive, integrative oncology approach to achieve a complete pathological remission of his CLL (chronic lymphocytic leukemia)—considered an "incurable" disease—without conventional intervention. Glenn's case has been chronicled through Dana-Farber Cancer Institute and his personal oncologist, Lee M. Nadler, MD, Dean of Clinical and Translational Medicine at Harvard Medical School. Read More at his website FON Therapeutics.
No comments:
Post a Comment